Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
24/09/2024 13:17
Sept 24 (Reuters) - Altamira Therapeutics Ltd CYTO.O :
* ALTAMIRA THERAPEUTICS PROVIDES BUSINESS UPDATE AND FIRST
HALF
2024 FINANCIAL RESULTS
* ALTAMIRA THERAPEUTICS LTD SAYS EXPECTS TOTAL CASH NEEDS IN
2024
TO BE IN RANGE OF $5.8 MILLION TO $7.0 MILLION
Source text for Eikon: ID:nGNXXmWrF
Further company coverage: CYTO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering